Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
p53 signaling pathway | R-HSA-168638 | map04115 | spiramycin | 5289394 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | mephentermine | 3677 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | mephentermine | 3677 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | mephentermine | 3677 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | fenbufen | 3335 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | fenbufen | 3335 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | fenbufen | 3335 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | fenbufen | 3335 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | fenbufen | 3335 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | fenbufen | 3335 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | fenbufen | 3335 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | fenbufen | 3335 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | fenbufen | 3335 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | fenbufen | 3335 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | trimethoprim | 5578 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | trimethoprim | 5578 | drug-path |
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | trimethoprim | 5578 | drug-path |
Shigellosis | 0 | map05131 | hydroxyzine | 3658 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | hydroxyzine | 3658 | drug-path |
SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | hydroxyzine | 3658 | drug-path |